Table 4

Serum biochemistry profiles by noise exposure status

Never exposed (n=5071)Current exposed (n=1236)Tertiles of accumulated exposure time
Short (n=421)Medium (n=399)Long (n=416)
Leukocytes (×109/l), mean (SE)7.2 (0.1)7.4 (0.1)*7.6 (0.1)* 7.2 (0.1)7.3 (0.1)
Platelets (×109/l), mean (SE)270.0 (1.3)265.8 (1.7)* 266.7 (3.6)266.6 (3.3)263.9 (3.3)
Haematocrit (%), mean (SE)42.4 (0.1)45.0 (0.2)*45.0 (0.3)*45.0 (0.3)*45.1 (0.3)*
Fibrinogen (g/l), mean (SE)3.52 (0.03)3.47 (0.06)3.47 (0.07)3.40 (0.08)3.52 (0.06)
CRP (mg/l), median (IQR)0.18 (0.06–0.42)0.15 (0.07–0.33)*0.13 (0.06–0.33)*0.14 (0.06–0.31)*0.17 (0.08–0.36)
Homocysteine (μmol/l), mean (SE)8.1 (0.1)8.7 (0.1)*8.3 (0.1)9.0 (0.3)*8.9 (0.1)*
Total cholesterol (mmol/l), mean (SE)5.19 (0.02)5.25 (0.05)5.08 (0.10)5.17 (0.07)5.50 (0.08)*
HDL-cholesterol (mmol/l), mean (SE)1.38 (0.01)1.24 (0.01)*1.24 (0.02)*1.23 (0.02)*1.25 (0.02)*
LDL-cholesterol (mmol/l), mean (SE)§3.10 (0.03)3.15 (0.04)2.99 (0.09)3.12 (0.07)3.31 (0.07)*
Triglyceride (mmol/l)§ 1.28 (1.02)1.40 (1.03)1.25 (1.05)1.32 (1.06)1.61 (1.05)*
Plasma glucose (mmol/l)§ 5.34 (1.01)5.49 (1.01)*5.33 (1.01)5.41 (1.01)5.72 (1.01)*
Serum insulin (pmol/l)§ **42.3 (1.0)42.0 (1.1)42.5 (1.1)40.5 (1.1)43.2 (1.1)
  • CRP, C-reactive protein; HDL, high-density lipoprotein cholesterol; IQR, interquartile range; LDL, low-density lipoprotein cholesterol; SE, standard error.

  • * p<0.05 compared with the never exposed group in bivariable analysis.

  • p <0.05 compared with the never exposed group after adjustment for age, sex, ethnicity, BMI, educational level, leisure time physical activity, cigarette smoking and diabetes (model 2).

  • Only available during NHANES 1999–2000, 2001–2002 for participants aged 40 years and older. Four-year weights were incorporated into this analysis. Number of participants in the current/never exposed group: 422/1721.

  • § This is a morning fasting sample; 6-year fasting weights were incorporated into the analysis. Number of participants in the current/never exposed group: LDL-cholesterol 519/2147, triglyceride 535/2202, plasma glucose 537/2229, serum insulin 533/2197.

  • Geometric mean (SE of the geometric mean).

  • ** Serum insulin level was measured using a Pharmacia method during NHANES 1999–2002 but a Tosoh method during NHANES 2003–2004. The Pharmacia values were transferred into the Tosoh values to keep insulin values consistent; two participants with negative transferred values were excluded from the analysis.